These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 23030612

  • 21. Toxicology and pharmacology of bispyridium oximes--insight into the mechanism of action vs Soman poisoning in vivo.
    Clement JG.
    Fundam Appl Toxicol; 1981; 1(2):193-202. PubMed ID: 6897946
    [Abstract] [Full Text] [Related]

  • 22. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
    Aurbek N, Thiermann H, Eyer F, Eyer P, Worek F.
    Toxicology; 2009 May 17; 259(3):133-9. PubMed ID: 19428953
    [Abstract] [Full Text] [Related]

  • 23. Kinetic analysis of interactions of different sarin and tabun analogues with human acetylcholinesterase and oximes: is there a structure-activity relationship?
    Aurbek N, Herkert NM, Koller M, Thiermann H, Worek F.
    Chem Biol Interact; 2010 Sep 06; 187(1-3):215-9. PubMed ID: 20105433
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Probing the role of amino acids in oxime-mediated reactivation of nerve agent-inhibited human acetylcholinesterase.
    Chambers C, Luo C, Tong M, Yang Y, Saxena A.
    Toxicol In Vitro; 2015 Mar 06; 29(2):408-14. PubMed ID: 25451328
    [Abstract] [Full Text] [Related]

  • 29. Reappraisal of indications and limitations of oxime therapy in organophosphate poisoning.
    Worek F, Bäcker M, Thiermann H, Szinicz L, Mast U, Klimmek R, Eyer P.
    Hum Exp Toxicol; 1997 Aug 06; 16(8):466-72. PubMed ID: 9292287
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A comparison of the efficacy of new asymmetric bispyridinium oxime BI-6 with other oximes (obidoxime, HI-6) against soman in rats.
    Kassa J.
    Hum Exp Toxicol; 1998 Jun 06; 17(6):331-5. PubMed ID: 9688357
    [Abstract] [Full Text] [Related]

  • 38. An in silico stereo-electronic comparison of conventional pyridinium oximes and K-oximes for organophosphate (OP) poisoning.
    Bhattacharjee AK, Kuca K, Musilek K, Gordon RK.
    Med Chem; 2012 Mar 06; 8(2):230-45. PubMed ID: 22385173
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of HI 6 treatment after percutaneous VR exposure by use of a kinetic-based dynamic computer model.
    Aurbek N, Thiermann H, Szinicz L, Worek F.
    Toxicology; 2007 Apr 20; 233(1-3):173-9. PubMed ID: 16904808
    [Abstract] [Full Text] [Related]

  • 40. Bispyridinium oximes as antidotal treatment of cyclosarin poisoning-in vitro and in vivo testing.
    Bartosova L, Kuca K, Jun D, Kunesova G.
    Int J Toxicol; 2005 Apr 20; 24(6):399-402. PubMed ID: 16393932
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.